119 related articles for article (PubMed ID: 37961527)
1. Programs, Origins, and Niches of Immunomodulatory Myeloid Cells in Gliomas.
Miller TE; El Farran CA; Couturier CP; Chen Z; D'Antonio JP; Verga J; Villanueva MA; Castro LNG; Tong YE; Saadi TA; Chiocca AN; Fischer DS; Heiland DH; Guerriero JL; Petrecca K; Suva ML; Shalek AK; Bernstein BE
bioRxiv; 2023 Oct; ():. PubMed ID: 37961527
[TBL] [Abstract][Full Text] [Related]
2. The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion.
Pinton L; Masetto E; Vettore M; Solito S; Magri S; D'Andolfi M; Del Bianco P; Lollo G; Benoit JP; Okada H; Diaz A; Della Puppa A; Mandruzzato S
J Immunother Cancer; 2019 Feb; 7(1):58. PubMed ID: 30813960
[TBL] [Abstract][Full Text] [Related]
3. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment.
Müller S; Kohanbash G; Liu SJ; Alvarado B; Carrera D; Bhaduri A; Watchmaker PB; Yagnik G; Di Lullo E; Malatesta M; Amankulor NM; Kriegstein AR; Lim DA; Aghi M; Okada H; Diaz A
Genome Biol; 2017 Dec; 18(1):234. PubMed ID: 29262845
[TBL] [Abstract][Full Text] [Related]
4. Immune microenvironment of gliomas.
Gieryng A; Pszczolkowska D; Walentynowicz KA; Rajan WD; Kaminska B
Lab Invest; 2017 May; 97(5):498-518. PubMed ID: 28287634
[TBL] [Abstract][Full Text] [Related]
5. A Novel Oral Arginase 1/2 Inhibitor Enhances the Antitumor Effect of PD-1 Inhibition in Murine Experimental Gliomas by Altering the Immunosuppressive Environment.
Pilanc P; Wojnicki K; Roura AJ; Cyranowski S; Ellert-Miklaszewska A; Ochocka N; Gielniewski B; Grzybowski MM; Błaszczyk R; Stańczak PS; Dobrzański P; Kaminska B
Front Oncol; 2021; 11():703465. PubMed ID: 34504786
[TBL] [Abstract][Full Text] [Related]
6. Specialized functions and sexual dimorphism explain the functional diversity of the myeloid populations during glioma progression.
Ochocka N; Segit P; Wojnicki K; Cyranowski S; Swatler J; Jacek K; Grajkowska W; Kaminska B
Cell Rep; 2023 Jan; 42(1):111971. PubMed ID: 36640350
[TBL] [Abstract][Full Text] [Related]
7. Myeloid-derived suppressor cells in gliomas.
Gieryng A; Kaminska B
Contemp Oncol (Pozn); 2016; 20(5):345-351. PubMed ID: 28373814
[TBL] [Abstract][Full Text] [Related]
8. Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages.
Ochocka N; Segit P; Walentynowicz KA; Wojnicki K; Cyranowski S; Swatler J; Mieczkowski J; Kaminska B
Nat Commun; 2021 Feb; 12(1):1151. PubMed ID: 33608526
[TBL] [Abstract][Full Text] [Related]
9. Mutant IDH1 promotes phagocytic function of microglia/macrophages in gliomas by downregulating ICAM1.
Ma D; Zhan D; Fu Y; Wei S; Lal B; Wang J; Li Y; Lopez-Bertoni H; Yalcin F; Dzaye O; Eberhart CG; Laterra J; Wilson MA; Ying M; Xia S
Cancer Lett; 2021 Oct; 517():35-45. PubMed ID: 34098063
[TBL] [Abstract][Full Text] [Related]
10. Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas.
Friedrich M; Sankowski R; Bunse L; Kilian M; Green E; Ramallo Guevara C; Pusch S; Poschet G; Sanghvi K; Hahn M; Bunse T; Münch P; Gegner HM; Sonner JK; von Landenberg A; Cichon F; Aslan K; Trobisch T; Schirmer L; Abu-Sammour D; Kessler T; Ratliff M; Schrimpf D; Sahm F; Hopf C; Heiland DH; Schnell O; Beck J; Böttcher C; Fernandez-Zapata C; Priller J; Heiland S; Gutcher I; Quintana FJ; von Deimling A; Wick W; Prinz M; Platten M
Nat Cancer; 2021 Jul; 2(7):723-740. PubMed ID: 35121943
[TBL] [Abstract][Full Text] [Related]
11. Dissecting intratumoral myeloid cell plasticity by single cell RNA-seq.
Song Q; Hawkins GA; Wudel L; Chou PC; Forbes E; Pullikuth AK; Liu L; Jin G; Craddock L; Topaloglu U; Kucera G; O'Neill S; Levine EA; Sun P; Watabe K; Lu Y; Alexander-Miller MA; Pasche B; Miller LD; Zhang W
Cancer Med; 2019 Jun; 8(6):3072-3085. PubMed ID: 31033233
[TBL] [Abstract][Full Text] [Related]
12. Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype.
Cejalvo T; Gargini R; Segura-Collar B; Mata-Martínez P; Herranz B; Cantero D; Ruano Y; García-Pérez D; Pérez-Núñez Á; Ramos A; Hernández-Laín A; Martín-Soberón MC; Sánchez-Gómez P; Sepúlveda-Sánchez JM
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33147752
[TBL] [Abstract][Full Text] [Related]
13. A map of the spatial distribution and tumour-associated macrophage states in glioblastoma and grade 4 IDH-mutant astrocytoma.
Yin W; Ping YF; Li F; Lv SQ; Zhang XN; Li XG; Guo Y; Liu Q; Li TR; Yang LQ; Yang KD; Liu YQ; Luo CH; Luo T; Wang WY; Mao M; Luo M; He ZC; Cao MF; Chen C; Miao JY; Zeng H; Wang C; Zhou L; Yang Y; Yang X; Wang QH; Feng H; Shi Y; Bian XW
J Pathol; 2022 Oct; 258(2):121-135. PubMed ID: 35723032
[TBL] [Abstract][Full Text] [Related]
14. Deciphering diffuse glioma immune microenvironment as a key to improving immunotherapy results.
Picca A; Finocchiaro G
Curr Opin Oncol; 2022 Nov; 34(6):653-660. PubMed ID: 36000367
[TBL] [Abstract][Full Text] [Related]
15. The presence of TIM-3 positive cells in WHO grade III and IV astrocytic gliomas correlates with isocitrate dehydrogenase mutation status.
Sørensen MD; Nielsen O; Reifenberger G; Kristensen BW
Brain Pathol; 2021 May; 31(3):e12921. PubMed ID: 33244787
[TBL] [Abstract][Full Text] [Related]
16. Immuno-phenotyping of IDH-mutant grade 3 astrocytoma and IDH-wildtype glioblastoma reveals specific differences in cells of myeloid origin.
Raghavan JV; Ganesh RA; Sonpatki P; Naik D; John AE; Arunachalam P; Shah D; P S H; Lakshmikantha A; Pillai S; Chandrachari KP; Mariswamappa K; Lale S; Shah N; Jhunjhunwala S
Oncoimmunology; 2021; 10(1):1957215. PubMed ID: 34377594
[TBL] [Abstract][Full Text] [Related]
17. Role of myeloid cells in the immunosuppressive microenvironment in gliomas.
Locarno CV; Simonelli M; Carenza C; Capucetti A; Stanzani E; Lorenzi E; Persico P; Della Bella S; Passoni L; Mavilio D; Bonecchi R; Locati M; Savino B
Immunobiology; 2020 Jan; 225(1):151853. PubMed ID: 31703822
[TBL] [Abstract][Full Text] [Related]
18. Identification of a unique tumor cell subset employing myeloid transcriptional circuits to create an immunomodulatory microenvironment in glioblastoma.
Yang K; Shi Y; Luo M; Mao M; Zhang X; Chen C; Liu Y; He Z; Liu Q; Wang W; Luo C; Yin W; Wang C; Niu Q; Zeng H; Bian XW; Ping YF
Oncoimmunology; 2022; 11(1):2030020. PubMed ID: 35096487
[TBL] [Abstract][Full Text] [Related]
19. Mutant IDH1 Enhances Temozolomide Sensitivity via Regulation of the ATM/CHK2 Pathway in Glioma.
Lin L; Cai J; Tan Z; Meng X; Li R; Li Y; Jiang C
Cancer Res Treat; 2021 Apr; 53(2):367-377. PubMed ID: 33070553
[TBL] [Abstract][Full Text] [Related]
20. Single-Cell Omics in Dissecting Immune Microenvironment of Malignant Gliomas-Challenges and Perspectives.
Kaminska B; Ochocka N; Segit P
Cells; 2021 Aug; 10(9):. PubMed ID: 34571910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
